Access cutting-edge myasthenia gravis treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.
Access myasthenia gravis specialists in Orange at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myasthenia gravis treatment provided free
This is a phase I/II study to assess safety, efficacy, and cellular kinetics of YTB323 in participants with treatment-resistant generalized myasthenia gravis. YTB323 is a Biological CAR-T cell therapy.
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this myasthenia gravis clinical trial in Orange, CA
If you're searching for myasthenia gravis treatment options in Orange, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myasthenia gravis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.